DE3851054D1 - Antitumor 6-sulfenamid, 6-sulfinamid und 6-sulfonamid-purine, purin-nukleoside, purin-nukleotide und verwandte verbindungen. - Google Patents

Antitumor 6-sulfenamid, 6-sulfinamid und 6-sulfonamid-purine, purin-nukleoside, purin-nukleotide und verwandte verbindungen.

Info

Publication number
DE3851054D1
DE3851054D1 DE3851054T DE3851054T DE3851054D1 DE 3851054 D1 DE3851054 D1 DE 3851054D1 DE 3851054 T DE3851054 T DE 3851054T DE 3851054 T DE3851054 T DE 3851054T DE 3851054 D1 DE3851054 D1 DE 3851054D1
Authority
DE
Germany
Prior art keywords
purin
sulfinamide
sulfenamide
nucleoside
sulfonamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3851054T
Other languages
English (en)
Other versions
DE3851054T2 (de
Inventor
Roland Robins
Ganapathi Revankar
Naeem Hanna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Valeant Pharmaceuticals International Inc USA
Original Assignee
NUCLEIC ACID RESEARCH INST
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NUCLEIC ACID RESEARCH INST filed Critical NUCLEIC ACID RESEARCH INST
Priority claimed from PCT/US1988/004393 external-priority patent/WO1989005817A1/en
Publication of DE3851054D1 publication Critical patent/DE3851054D1/de
Application granted granted Critical
Publication of DE3851054T2 publication Critical patent/DE3851054T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/14—Pyrrolo-pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE3851054T 1987-12-14 1988-12-13 Antitumor 6-sulfenamid, 6-sulfinamid und 6-sulfonamid-purine, purin-nukleoside, purin-nukleotide und verwandte verbindungen. Expired - Fee Related DE3851054T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13314387A 1987-12-14 1987-12-14
US07/275,113 US5026836A (en) 1987-12-14 1988-11-22 6-sulfenamide, 6-sulfinamide and 6-sulfonamide purines, purine nucleosides, purine nucleotides, pharmaceutical compositions, and processes of making
PCT/US1988/004393 WO1989005817A1 (en) 1987-12-14 1988-12-13 Antitumor 6-sulfenamide, 6-sulfinamide and 6-sulfonamide purines, purine nucleosides, purine nucleotides and related compounds

Publications (2)

Publication Number Publication Date
DE3851054D1 true DE3851054D1 (de) 1994-09-15
DE3851054T2 DE3851054T2 (de) 1995-03-09

Family

ID=26831092

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3851054T Expired - Fee Related DE3851054T2 (de) 1987-12-14 1988-12-13 Antitumor 6-sulfenamid, 6-sulfinamid und 6-sulfonamid-purine, purin-nukleoside, purin-nukleotide und verwandte verbindungen.

Country Status (9)

Country Link
US (1) US5026836A (de)
EP (1) EP0353268B1 (de)
JP (1) JP2698460B2 (de)
KR (1) KR0137763B1 (de)
AR (1) AR247218A1 (de)
AT (1) ATE109791T1 (de)
AU (1) AU2816789A (de)
DE (1) DE3851054T2 (de)
GR (1) GR1000386B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04501254A (ja) * 1988-05-23 1992-03-05 アメリカ合衆国 癌治療剤としてのサイクリックａｍｐ誘導体
US6069132A (en) * 1996-08-14 2000-05-30 Revanker; Ganapathi R. Phosphazole compounds
US6531477B1 (en) * 1998-10-13 2003-03-11 Dupont Pharmaceuticals Company 6-substituted pyrazolo [3,4-d] pyrimidin-4-ones useful as cyclin dependent kinase inhibitors

Also Published As

Publication number Publication date
JP2698460B2 (ja) 1998-01-19
GR1000386B (el) 1992-06-30
KR900700498A (ko) 1990-08-13
ATE109791T1 (de) 1994-08-15
AR247218A1 (es) 1994-11-30
US5026836A (en) 1991-06-25
DE3851054T2 (de) 1995-03-09
JPH02502912A (ja) 1990-09-13
AU2816789A (en) 1989-07-19
EP0353268A4 (de) 1990-05-14
KR0137763B1 (ko) 1998-04-30
EP0353268B1 (de) 1994-08-10
EP0353268A1 (de) 1990-02-07

Similar Documents

Publication Publication Date Title
DE3873936D1 (de) Lipoxygenasehemmende verbindungen.
DE68917107D1 (de) Stabilisierte Sucralosekomplexe.
DE3888821D1 (de) Tricyclische Verbindungen.
DE3675422D1 (de) Lipoxygenasehemmende verbindungen.
FI881152A0 (fi) Foerfarande foer framstaellning av tiazolderivat, med kolinergisk aktivitet.
DE3675421D1 (de) Lypoxygenasehemmende verbindungen.
DE3851114D1 (de) Trizyklische Verbindungen.
DE68921298T2 (de) Herzschützende tocopherolähnliche Verbindungen.
ATE94537T1 (de) Arylpiperazinylalkylenphenylheterocyclische verbindungen.
DE68912818D1 (de) Antitumormittel.
NO865216L (no) Sintringshindrende middel for gjoedningsmiddel.
DE68916444D1 (de) Sekretorische e-coli-stämme.
DE3880991T2 (de) Aminoanthracendion-bis-platinkomplexe, nützlich als Antitumor-Agenzien.
DE3851054D1 (de) Antitumor 6-sulfenamid, 6-sulfinamid und 6-sulfonamid-purine, purin-nukleoside, purin-nukleotide und verwandte verbindungen.
DE58906190D1 (de) Cyclische metallorganische Verbindungen.
FI880577A0 (fi) Styrorgan foer en anordning, saosom en elektrisk brytare, i form av en vaendbar tapp.
DE3861252D1 (de) Antihypercholesterinaemische verbindungen.
ATE126217T1 (de) Phenoxyheterozyklische verbindungen.
ES2017452A4 (es) Procesos de lecho fluidificado.
ATE128711T1 (de) Pestizide verbindungen.
DE3866858D1 (de) Tricyclische verbindungen.
DE68924399T2 (de) Antitumor-Verbindungen.
DE3768393D1 (de) Alicyclische verbindungen.
FI880073A0 (fi) Ramspaennanordning, saerskilt foer girfogning av ramar.
DE3889583D1 (de) Kationische Verbindungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ICN PHARMACEUTICALS, INC. (N.D. GES. D. STAATES DE

8339 Ceased/non-payment of the annual fee